Clinical Trials Browser

Phase 1 × Glioma × Ipilimumab × Clear all

NCT04943848 2026-03-17

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Phase 1 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma

NCT02829931 2023-01-19

Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas

Phase 1 Completed

Glioma